My name is Gleb. I am the founder and main operator of ASPERIS.

I hold a bachelors in Chemistry from The University of Texas at Austin, where  I spent a year working in the group of Prof. Jason Shear on projects using multi-photon lithography.

After my bachelors, I completed a PhD in Chemical and Bioprocess Engineering from University College Dublin, Ireland studying protein dynamics and unfolding under stress conditions, using large scale molecular simulation.

Driven by my interest in protein dynamics, I worked as a post-doc in the group of Prof. Mikael Akke at Lund Universities LTH, using a combined experimental and computational approach to study the mechanisms of entropy compensation in protein-drug binding.

Transitioning away from pure research, I completed an MSc from the Lund University School of Economics and shortly thereafter joined Novozymes in Copenhagen, Denmark. I spent several years as a commercial development manager working with the Animal Feed Industry via our alliance partner DSM. Working at the intersection of R&D, IPR, Supply Chain and Sales, my responsibility was to match interesting problems to the Novozymes technology in a commercially feasible way.

These experiences are the cumulative foundation for ASPERIS. Driven by curiosity and the desire to work with new teams and technologies, I bring my technical and commercial experience to early stage ventures and provide clarity and rationale for early strategic/financing decisions.